PlasmaGen BioSciences - About the company
PlasmaGen BioSciences is a series D company based in Bengaluru (India), founded in 2010 by Vinod Nahar. It operates as a Biopharmaceutical company offering plasma management services. PlasmaGen BioSciences has raised $84.5M in funding from investors like Eight Roads Ventures, Vins Bio Products and F-Prime Capital, with a current valuation of $*****. The company has 1883 active competitors, including 98 funded and 201 that have exited. Its top competitors include companies like AbbVie, Gilead and Amgen.
Company Details
Biopharmaceutical company offering plasma management services. It also offers sales & marketing solutions. It offers hematology, oncology, and other plasma products. It partners with manufacturers to produce treatments for medical fields like neurology, hematology, oncology, immunology, and critical care.
- Website
- plasmagen.com
- Social
- Email ID
- *****@plasmagen.in
- Phone Number
- +91 **********
- Registered Address
- No. 160, KCI Chambers, 2nd Floor, 5th Main Road, Chamarajpet, Bangalore, Karnataka, India, 560018
Key Metrics
Founded Year
2010
Location
Bengaluru, India
Stage
Series D
Total Funding
$84.5M in 5 rounds
Latest Funding Round
Post Money Valuation
$***** as on Dec 05, 2025
Investors
Ranked
27th among 1883 active competitors
Annual Revenue
₹100 - ₹500 Cr as on Mar 31, 2025
Employee Count
417 as on Aug 31, 2025
Legal entities associated with PlasmaGen BioSciences
PlasmaGen BioSciences is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
PLASMAGEN BIOSCIENCES PRIVATE LIMITED CIN: U51909KA2010PTC055077 , India, Active | Sep 07, 2010 | ₹100 - ₹500 Cr (As on Mar 31, 2025) | 386 (As on Feb 01, 2026) |
Sign up to download PlasmaGen BioSciences' company profile
PlasmaGen BioSciences's funding and investors
PlasmaGen BioSciences has raised a total funding of $84.5M over 5 rounds. Its first funding round was on Jul 14, 2017. Its latest funding round was a Series D round on Dec 05, 2025 for $*****. 2 investors participated in its latest round. PlasmaGen BioSciences has 15 institutional investors and 14 angel investors.
Here is the list of recent funding rounds of PlasmaGen BioSciences:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Dec 05, 2025 | 7576959 | Series D | 1826482 | 8443253 | 1379823 | 2776111 |
Sep 19, 2024 | 7682557 | Series C | 6100627 | 7549423 | 7868319 | |
Mar 10, 2023 | 4279320 | Series C | 6927723 | 4572169 |
Access funding benchmarks and valuations. Sign up today!View details of PlasmaGen BioSciences's funding rounds and investors
PlasmaGen BioSciences' founders and board of directors
Founder? Claim ProfileThe founders of PlasmaGen BioSciences is Vinod Nahar. Vivek Vasudev Kamath is the CEO of PlasmaGen BioSciences.
Here are the details of PlasmaGen BioSciences' key team members:
- Vinod Nahar: Co-Founder & Managing Director of PlasmaGen BioSciences. They serve on the board of 1 company.Contact Info: 1 phone number
- Vivek Vasudev Kamath: CEO of PlasmaGen BioSciences.
PlasmaGen BioSciences' Board of Directors
PlasmaGen BioSciences's board has 4 active members. Vinod Nahar, Robert Mark Weisskoff, Rahul Jain and Gopal Sarda are part of team.Here is the list of PlasmaGen BioSciences' board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Team | - | Current | 7y 7m | |
ljszkno | Team | - | Current | 5y 9m |
Investor | F-Prime Capital | Current | 9y 1m | |
Investor | RSM Pharma | Current | 9y 2m |
View details of PlasmaGen BioSciences's Founder profiles and Board Members
PlasmaGen BioSciences' employee count trend
PlasmaGen BioSciences has 417 employees as of Aug 25. The total employee count is 23.0% more than what it was in Aug 24. Here is PlasmaGen BioSciences's employee count trend over the years:
Uncover PlasmaGen BioSciences' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
PlasmaGen BioSciences's Competitors and alternates
Top competitors of PlasmaGen BioSciences include AbbVie, Gilead and Amgen. Here is the list of Top 10 competitors of PlasmaGen BioSciences, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | AbbVie 2012, Chicago (United States), Public | Research-based biopharmaceutical company | $14.7B | 83/100 | |
2nd | Gilead 1987, Foster City (United States), Acquired | Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | - | 81/100 | |
3rd | Amgen 1980, Thousand Oaks (United States), Public | Developer of pharmaceutical products for treating multiple diseases | - | 79/100 | |
4th |  AstraZeneca 1999, Cambridge (United Kingdom), Public | Developer of pharmaceutical medicines for oncology and various chronic diseases | - | 76/100 | |
5th | Lilly 1876, Indianapolis (United States), Public | Developer of traditional pharmaceutical medicines | - | 75/100 | |
6th |  Johnson & Johnson 1886, New Brunswick (United States), Public | Manufacturer and supplier of beauty care products, medical devices, and pharmaceutical products | - | 74/100 | |
7th |  Roivant Sciences 2014, New York City (United States), Public | Developer of therapeutics to treat neurology, oncology, rare, and endocrinology based diseases | $1.3B | 71/100 | |
8th | Novartis 1996, Basel (Switzerland), Acquired | R&D focused on manufacturing of drugs for multiple therapeutic areas | - | 71/100 | |
9th |  Roche 1896, Basel (Switzerland), Public | Developer of pharmaceuticals and diagnostics kits | - | 70/100 | |
10th | Genentech 1976, San Francisco (United States), Acquired | R&D company focused on manufacturing drugs for multiple therapeutic areas | $72.5M | 68/100 | |
27th | PlasmaGen BioSciences 2010, Bengaluru (India), Series D | Biopharmaceutical company offering plasma management services | $84.5M | 63/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on PlasmaGen BioSciences's competitors? Click here to see the top ones
PlasmaGen BioSciences's Latest cap tables and shareholding
Founders own 3.36%, Funds (largest shareholder) own 47.53%, Enterprises own 11.95% and Angels own 24.68%. The net worth of PlasmaGen BioSciences's founders is INR 51.4Cr as of Dec 05, 2025.
Shareholders Name | Post Round Holding % | Net worth | Cumulative Investment | Realised Returns | Unrealised Returns | Return Multiple |
|---|---|---|---|---|---|---|
Founder | 3.36% | 51.4Cr | 754 | 554 | 850 | 538 |
969 | 767 | 427 | 982 | 916 | 392 | |
Fund | 47.53% | 728Cr | 7830331 | 1383258 | 5962360 | 8351160 |
5440914 | 2756008 | 3964162 | 2395661 | 3111915 | 2164806 | |
7366988 | 1667784 | 1827076 | 9112995 | 4422987 | 5861514 | |
Enterprise | 11.95% | 183Cr | 3781582 | 9988362 | 4585012 | 5712048 |
Angel | 24.68% | 378Cr | 2698234 | 8454919 | 4039306 | 3326278 |
8 | 5 | 6 | 4 | 2 | 3 | |
0 | 0 | 0 | 0 | 0 | 0 | |
Other People | 9.42% | 144Cr | 6446016 | 6502869 | 6606905 | 1805233 |
ESOP Pool | 3.06% | 46.9Cr | 601 | 735 | 820 | 483 |
Total | 100.00% | 1,530Cr | 7072591 | 3479588 | 3448596 | 2759346 |
To unlock detailed Cap Table of PlasmaGen BioSciences Sign up today!Notes: The column Net Worth represents the net worth of investments made by that entity, as per the latest cap table.
DisclaimerView more details of PlasmaGen BioSciences's Shareholding
PlasmaGen BioSciences's Investments and acquisitions
PlasmaGen BioSciences has made no investments or acquisitions yet.
Reports related to PlasmaGen BioSciences
Here is the latest report on PlasmaGen BioSciences's sector:
News related to PlasmaGen BioSciences
Media has covered PlasmaGen BioSciences for a total of 3 events in the last 1 year, 1 of them has been about people movement.
•
Indian Startup Funding Weekly Report: $95.54 Million Raised [Dec 22- Dec 27]Entrackr•Dec 27, 2025•Wow! Momo, Dugar Finance, Coreel, PlasmaGen BioSciences and 1 other
•
PlasmaGen raises Rs 150 Cr led by ViNS BioproductsYourStory•Dec 22, 2025•Vins Bio Products, PlasmaGen BioSciences, Eight Roads Ventures
•
Plasmagen Biosciences appoints Vivek V Kamath as CEOIndiaMedToday•Oct 07, 2025•PlasmaGen BioSciences, Abbott
•
Plasmagen Biosciences taps into the niche Indian Biopharmaceutical market with the launch of CSL’s Haemocomplettan® P.globalprimenews.com•Jun 20, 2024•PlasmaGen BioSciences, CSL
•
PlasmaGen raises Rs 225 Cr in new equity roundYourStory•Dec 14, 2023•PlasmaGen BioSciences, Artian, Eight Roads Ventures, F-Prime Capital and 1 other
•
PlasmaGen Biosciences opens manufacturing facility for blood plasma products in Kolar, BengaluruIndiaMedToday•May 31, 2023•PlasmaGen BioSciences
•
PlasmaGen Biosciences Opens New, State-of-the-Art Manufacturing Facility for Blood Plasma Products in Kolar, BengaluruAsian News International•May 30, 2023•PlasmaGen BioSciences
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about PlasmaGen BioSciences
Explore our recently published companies
- Groupe PBI - France based, Unfunded company
- KASK SAFETY - Italy based, 2004 founded, Unfunded company
- The Connectium - Unfunded company
- Bahcvan Gda - Turkey based, 1956 founded, Unfunded company
- Pine Hill Park - Unfunded company
- Sidubara Consulting - Finland based, 2025 founded, Unfunded company
